During Friday’s Current trade, Shares of XenoPort, Inc.(NASDAQ:XNPT), lost -2.49% to $4.30.
XenoPort, Inc. (XNPT) declared positive preliminary top-line results from its Phase 2 clinical trial of XP23829 as a potential treatment for moderate-to-severe chronic plaque-type psoriasis. XP23829 met its primary endpoint in both 800 mg once daily and 400 mg twice daily doses, demonstrating statistically noteworthy improvements in percent change from baseline to week 12 in Psoriasis Area and Severity Index (PASI) score. XP23829 is a patented prodrug of monomethyl fumarate (MMF) in a novel oral formulation that was designed to potentially offer physicians and patients an effective, better tolerated and easier to use therapeutic option to presently accessible fumarate products.
Richard Kim, M.D., chief medical officer of XenoPort, stated, “We believe these clinical data demonstrate for the first time that a MMF prodrug other than dimethyl fumarate (DMF) can be effective in reducing lesions in psoriatic patients. The magnitude of XP23829’s effect on the primary efficacy endpoint met our expectations for this relatively short duration trial and we are particularly encouraged by the results with 800 mg once-daily dosing. Based on what is known about fumarates, we believe that the efficacy of XP23829 is likely to improve with a more extended duration of treatment beyond 12 weeks. We are also happy with the safety and tolerability profile of XP23829 emerging from this study. We believe that this demonstration of efficacy, safety and tolerability of XP23829 could lead to a differentiated product in psoriasis. We also believe that there is potential for the observations from this study to read through to other potential indications such as multiple sclerosis (MS).”
XenoPort, Inc., a biopharmaceutical company, focuses on developing and commercializing a portfolio of product candidates for the treatment of neurological and other disorders. It offers HORIZANT (gabapentin enacarbil) extended-release tablets for the treatment of moderate-to-severe primary restless legs syndrome in adults and for the administration of postherpetic neuralgia in adults.
Shares of Fluor Corporation (NEW)(NYSE:FLR), declined -1.86% to $43.83, during its current trading session.
Fluor Corporation (FLR) declared that the company has been awarded a contract by the Department of Homeland Security’s Federal Emergency Administration Agency (FEMA) to provide architectural and engineering services to support disaster-related operations in Texas following the severe thunderstorms, tornadoes and flooding that swept through the state in May.
Fluor’s contract is one of two task order contracts declared by FEMA for disaster response services in Texas. The contract was issued under the Architects and Engineers Technical Assistance Contract, which carries out the statutory authorities of the Robert T. Stafford Disaster Relief and Emergency Assistance Act. The contract has a six-month base period with an additional six-month option period. The unrevealed contract amount will be booked in the third quarter.
Fluor Corporation, through its auxiliaries, provides engineering, procurement, construction, fabrication and modularization, commissioning and maintenance, and project administration services worldwide. The company operates in five segments: Oil & Gas, Industrial & Infrastructure, Government, Global Services, and Power.
SolarCity Corp (NASDAQ:SCTY), during its Friday’s current trading session gained 0.36% to $48.68.
The Northern and Central California SunShot Alliance declared plans to construct and interconnect rooftop solar systems in one day or less, an unprecedented aim given the industry’s current average of 30 days. In a contest sponsored by the U.S. Department of Energy SunShot Initiative, teams made up of local governments, solar and technology companies, and electric utilities will compete for a total of $10 million in cash prizes that will go back into local communities.
The alliance, which comprises Pacific Gas and Electric Company, SolarCity, Qado Energy, Accela and the City of Livermore, will compete in the small systems category (1 - 100 kW) for a first-place prize of $3 million and second-place prize of $1 million. The potential winnings would be split between the City of Livermore and possibly other jurisdictions that will use the funds to enhance the solar experience in their communities. The alliance is also eligible for the Change Prize Award of $100,000, which will be used to develop necessary technologies and recruit additional jurisdictions to join the team.
SolarCity Corporation designs, manufactures, installs, maintains, monitors, leases, and sells solar energy systems to residential, commercial, government, and other customers in the United States.
Finally, SAP SE (ADR) (NYSE:SAP), decreased -2.45%, to $65.43.
Velocity Technology Solutions, Inc. (Velocity), a global leader in cloud application hosting for enterprise and business software, declared recently a contract with SAP (NYSE: SAP) to provide a partner managed cloud for SAP® software solutions. Velocity will offer an affordable, ready-to-use, subscription-based offering of SAP solutions in its private hosted cloud, enabling customers to access SAP software quickly and easily without the need for up-front infrastructure costs associated with on-premise software deployments.
As a provider of a partner managed cloud, Velocity Technology Solutions will provide customers with a cost-effective, on-demand, cloud-based delivery model of their SAP software solutions. Velocity will supplement these services with application migration, implementation, administration and support services.
SAP SE provides application and analytics software and software-related services for enterprises worldwide. The company offers solutions covering various lines of businesses, counting asset administration, commerce, finance, human resources, manufacturing, marketing, sales, service, sourcing and procurement, supply chain, and sustainability, in addition to research and development, and engineering.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
